Literature DB >> 18060642

Inhibitory effect of HCPT on expression of HIF-1alpha and downstream genes in hypoxic human cervical SiHa cancer cells.

Wei Shi1, Shiying Yu.   

Abstract

The hypoxic model to simulate hypoxic microenvironment in solid tumors was established and the effect of hydrocamptothecin (HCPT) on the hypoxia-induced over-expression of HIF-1alpha and VEGF genes was explored. Human cervical cancer SiHa cells were cultured in vitro under hypoxic conditions (37 degrees C, 5% CO(2), 1% O(2)) and treated with different concentrations of HCPT for 24 h. The mRNA and protein expression levels of HIF-1alpha, VEGF and Glut1 in SiHa cells were detected by semi-quantitative RT-PCR and Western blot respectively. Normoxic control groups were exposed to normoxic conditions for 24 h. Under normoxic conditions, HCPT had no obvious effects on the HIF-1alpha and VEGF gene expression. Hypoxia induced the up-regulation of HIF-1alpha protein and downstream VEGF gene, and HCPT showed a dose-dependently inhibitory effect on the hypoxia-induced over-expression of HIF-1alpha protein and VEGF gene expression in SiHa cells, whereas HCPT had no significant effect on the HIF-1alpha mRNA expression. No difference in HCPT cytotoxicity was observed between hypoxic groups and normoxic control groups. It was suggested that HCPT could inhibit the expression of HIF-1alpha protein and downstream VEGF gene in hypoxic SiHa cells in a dose-dependent manner, and the inhibitory effect was not related with HCPT cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18060642     DOI: 10.1007/s11596-007-0528-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  13 in total

1.  Transcriptional expression of the genes implicated in angiogenesis and tumor invasion in cervical carcinomas.

Authors:  Koji Kanda; Masatsugu Ueda; Hikari Futakuchi; Hiroyuki Yamaguchi; Kuniko Mori; Yoshito Terai; Minoru Ueki
Journal:  Gynecol Oncol       Date:  2005-09       Impact factor: 5.482

2.  Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer.

Authors:  P Birner; M Schindl; A Obermair; C Plank; G Breitenecker; G Oberhuber
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

3.  Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors.

Authors:  R Masood; J Cai; T Zheng; D L Smith; D R Hinton; P S Gill
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

Review 4.  Vascular endothelial growth factor and angiogenesis.

Authors:  Ann Hoeben; Bart Landuyt; Martin S Highley; Hans Wildiers; Allan T Van Oosterom; Ernst A De Bruijn
Journal:  Pharmacol Rev       Date:  2004-12       Impact factor: 25.468

5.  V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression.

Authors:  B H Jiang; F Agani; A Passaniti; G L Semenza
Journal:  Cancer Res       Date:  1997-12-01       Impact factor: 12.701

6.  The prognostic effect of VEGF expression in squamous cell carcinoma of the cervix treated with radiation therapy alone.

Authors:  Jin-Oh Kang; Seong-Eon Hong
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

7.  Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours.

Authors:  A M Jubb; T Q Pham; A M Hanby; G D Frantz; F V Peale; T D Wu; H W Koeppen; K J Hillan
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

8.  Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer.

Authors:  Barbara Bachtiary; Monika Schindl; Richard Pötter; Bettina Dreier; Thomas Hendrik Knocke; Johannes A Hainfellner; Reinhard Horvat; Peter Birner
Journal:  Clin Cancer Res       Date:  2003-06       Impact factor: 12.531

9.  Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.

Authors:  Annamaria Rapisarda; Badarch Uranchimeg; Dominic A Scudiero; Mike Selby; Edward A Sausville; Robert H Shoemaker; Giovanni Melillo
Journal:  Cancer Res       Date:  2002-08-01       Impact factor: 12.701

10.  Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications.

Authors:  Annamaria Rapisarda; Badarch Uranchimeg; Olivier Sordet; Yves Pommier; Robert H Shoemaker; Giovanni Melillo
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.